6.78
-0.02 (-0.29%)
| Previous Close | 6.80 |
| Open | 6.89 |
| Volume | 34,599 |
| Avg. Volume (3M) | 80,760 |
| Market Cap | 1,316,401,280 |
| Price / Sales | 44.19 |
| Price / Book | 29.90 |
| 52 Weeks Range | |
| Earnings Date | 4 Sep 2025 - 8 Sep 2025 |
| Profit Margin | -67.73% |
| Operating Margin (TTM) | -115.65% |
| Diluted EPS (TTM) | -0.080 |
| Quarterly Revenue Growth (YOY) | 40.80% |
| Total Debt/Equity (MRQ) | 25.78% |
| Current Ratio (MRQ) | 3.17 |
| Operating Cash Flow (TTM) | -12.93 M |
| Levered Free Cash Flow (TTM) | -14.06 M |
| Return on Assets (TTM) | -19.93% |
| Return on Equity (TTM) | -55.43% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | SS Innovations International In | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 4.0 |
| Average | 1.75 |
|
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Growth |
| % Held by Insiders | 83.38% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 02 Oct 2025 | Announcement | SS Innovations Provides U.S. Regulatory Update for the SSi Mantra Surgical Robotic System |
| 26 Sep 2025 | Announcement | SS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer |
| 16 Sep 2025 | Announcement | SS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System |
| 09 Sep 2025 | Announcement | SS Innovations Announces Successful Completion of First Robotic Telesurgery Performed from the Company’s MantraM Mobile Robotic Telesurgery Unit |
| 07 Aug 2025 | Announcement | SS Innovations Reports Second Quarter 2025 Financial Results |
| 22 Jul 2025 | Announcement | SS Innovations Announces Completion of World’s First Intercontinental Robotic Cardiac Telesurgery |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |